• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-21A
Device Problems Material Separation (1562); Material Split, Cut or Torn (4008)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 09/03/2022
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2018, a 21mm trifecta valve was successfully implanted.On (b)(6) 2022, during a routine check, severe aortic regurgitation was detected.The patient's gradient during the preoperative echo was 45mmhg.On imaging, the physician observed dehiscence of the tissue between the non-coronary and left coronary artery, near the valve post of the trifecta valve.The valve was emergently explanted on (b)(6) 2022 and lasix and warfarin were administered.A 21mm non-abbott valve was then implanted as a replacement.The gradient following the replacement valve was implanted was read at 15mmhg.The patient was reported as stable.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
An event of regurgitation and explant of the valve was reported.The device history record was also reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.However, four images were received from the field.Three of the photos appeared to show the valve still implanted, and a tear appeared to be present at one of the stent posts.The last appeared to show an explanted trifecta valve where two of the leaflets appeared prolapsed, consistent with a tear at a stent post.A ring of white tissue was also present in the image, but was not clear if it had come from the valve.Based on the information received, the reported leaflet tear is consistent with structural valve deterioration (svd), specifically non-calcific leaflet tear, which is a well-known complication of tissue heart valve replacement surgery.A variety of factors may contribute to svd, including patient, biological, and implant related factors.No implant related factors could be confirmed from the information received from the field as information related to implant procedure was not provided.However, a images provided from the field indicated a leaflet tear but did not appear to show calcification, thereby ruling out another type of svd, fibrocalcific svd.Biological factors which can result in tissue degeneration such as calcification (from patient conditions predisposing to elevated calcium like renal disease etc.) or thinning of the prosthetic leaflet tissue (predisposing to leaflet tears) could not be confirmed as the valve was not returned for histopathological examination.There is no indication of a product quality issue with regards to manufacture, design, or labeling.H6 medical device problem code: code 1562 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15936765
MDR Text Key305042434
Report Number2135147-2022-02374
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/07/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/13/2022
Device Model NumberTF-21A
Device Catalogue NumberTF-21A
Device Lot NumberBR00015453
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/15/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age61 YR
Patient SexMale
-
-